May 17, 20244C2X’s Strategic Partnership With SunGas Renewables For Beaver Lake Renewable Energy Project
May 15, 20244Dalian Wanda Commercial Management’s $8.3bn Investment Agreement with Zhuhai Wanda Commercial Management
June 21, 20234Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture
June 19, 20234The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.
Homepage Europe Europe Legal Chronicle Doc Generici’s Acquisition Of Muscoril Drug From Sanofi Doc Generici’s Acquisition Of Muscoril Drug From Sanofi May 7, 2024 Marco Zingaro Tagged: 5-7-2024 Alban Zaimaj Alberto Salvadé Bird & Bird Cristiano Garbarini DOC Generici Edoardo Corò Erika Brini Raimondi Gaël Saint Olive Jay Sadanandan Jones Day Latham & Watkins Marcello Bragliani Maurizio Pinto Pasquale Spiezio PedersoliGattai Sanofi S.A. Stefano Crosio William Lam Zahra Haji On the deal, Doc Generici is supported by Bird&Bird for the legal aspects, by Latham & Watkins for the financial ones and by PedersoliGattai for the… This content is for Standard 1 Year members only.Login Join Now
